Nachrichten zur AstraZeneca PLC Aktie

FDA Grants Priority Review to AZNs Filing for Rare Bone Disease Drug

AstraZeneca wins FDA priority review for efzimfotase alfa, potentially expanding its HPP treatment opportunity with less frequent dosing.…

AstraZeneca shares oversold after trial flops and merger talk, says UBS

UBS has told investors that the recent slide in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares has gone too far, keeping its…

AstraZeneca Aktie: Das Sell-Signal ist weg!

Bad Marienberg (www.aktiencheck.de) - Die Deutsche Bank wird bei der AstraZeneca-Aktie vorsichtig optimistischer. In ihrer AstraZeneca-Aktienanalyse vom 15. September 2026…

AstraZenecas news flow next year could sustain drugs group beyond 2030, says leading bank

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) offers the richest run of drug news in the pharmaceuticals sector over the next 18 months,…

AstraZeneca Aktie: UBS wird nach Studienrückschlägen deutlich vorsichtiger

Bad Marienberg (www.aktiencheck.de) - Bei AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London Stock Exchange-Symbol: AZN) prallen derzeit zwei…

Why the Market Dipped But Astrazeneca (AZN) Gained Today

In the latest trading session, Astrazeneca (AZN) closed at $163.78, marking a +2.25% move from the previous day.…

VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in the Human Sp

By Steven Ralston, CFANYSE: VNRXREAD THE FULL VNRX RESEARCH REPORTEXECUTIVE OVERVIEWVolitionRx Limited (NYSE: VNRX) continues to advance its multi-pillar epigenetics…

AstraZeneca breast cancer drug fails trial but Citi keeps buy rating

AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) experimental breast cancer drug camizestrant has failed a late-stage trial, though analysts at Citi say the…

AstraZeneca: The $5 Billion Pipeline Hole Did Not Stay Open Long

…

AstraZenecas Etcamah fails in late-stage trial as first-line breast cancer treatment

…

AstraZeneca breast cancer drug fails late-stage trial goal

AstraZeneca breast cancer drug fails late-stage trial goal…

AMGN, AZN Drug Combo Shows Survival Benefit in Lung Cancer Study

Amgen and AstraZenecas Imdelltra-Imfinzi combo shows survival benefits in first-line ES-SCLC, potentially broadening both drugs reach.…

AstraZenecas $5bn drug promise is no buy signal for Deutsche

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drew praise from Deutsche Bank for tozorakimabs lung disease data, but the broker paired its positive…

AstraZenecas $5bn drug promise is no buy signal for Deutsche

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drew praise from Deutsche Bank for tozorakimabs lung disease data, but the broker paired its positive…

AstraZeneca Sell

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca mit einem Kursziel von 11500 Pence auf "Sell" belassen. Der Pharmakonzern…

AstraZeneca COPD data back Citis $7b peak sales case

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drew Citis backing after tozorakimab trial results, supporting an upside case of at least $7 billion…

Amgen and AstraZeneca report positive lung cancer trial results

Amgen and AstraZeneca report positive lung cancer trial results…

Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval

Citi has flagged AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) accelerated approval for Etcamah, known chemically as camizestrant, as a meaningful sentiment...…

Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval

Citi has flagged AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) accelerated approval for Etcamah, known chemically as camizestrant, as a meaningful sentiment...…

AstraZeneca: Share price weakness of late, should be capitalised on

Target changeChange in target pricep 14,380 vs 15,038 -4.38%We have tweaked our earnings estimates lower and considering the recent late-stage…

CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor

By Tom Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORTNew Findings Presented at European Society of Cardiology (ESC) Congress 2026On…

AZNs Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal

AstraZeneca reports positive SANOVO data, showing Tagrisso plus Orpathys improved PFS in first-line EGFR-mutated NSCLC.…

Top Stock Reports for AMD, Costco & AstraZeneca

AMD, Costco and AstraZeneca headline todays stock reports, with AI demand, membership growth and drug pipelines shaping their outlooks.…

Admission of Further Securities to Trading

1 September 2026Notification of Admission of Further Securities to Trading (PRM 1.6.4R)The following notification is made in accordance with The…

Total Voting Rights

1 September 2026Total Voting RightsThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure and Transparency…

AstraZeneca drug succeeds in trial for swallowing disorder

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) said its drug Tezspire worked in a late-stage trial of patients with eosinophilic esophagitis, a chronic…

AstraZeneca’s Tezspire meets trial goals for esophagitis

AstraZeneca’s Tezspire meets trial goals for esophagitis…

AstraZenecas asthma drug Tezspire meets all goals in late-stage esophagitis trial

AstraZeneca said on Thursday ?its asthma drug, Tezspire, developed with Amgen , ?met its main and secondary goals in a…

AstraZeneca prices €2.55bn euro bond sale across four tranches

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharma group, has priced a €2.55 billion bond offering, tapping the euro debt…

FTSE 100 Live: London opens flat as AstraZeneca offsets modest gains

FTSE 100 slips 0.06% to 10,810 Airtel Africa and Halma lead early risers AstraZeneca falls around 1% Gold holds near…

FTSE 100 Live: Miners lift London as oil and pharmaceutical stocks retreat

FTSE 100 rises 0.2% to 10,838 Mid-caps and AIM move slightly higher Mining, financial and industrial shares lead BP, AstraZeneca…

AstraZeneca Vs. Bristol-Myers Squibb: Whos The Better Bargain For Investors?

…

AstraZeneca maintains Citi buy rating despite mixed pipeline updates

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has retained a buy rating from Citi following a mixed set of pipeline updates, with the…

AstraZeneca maintains Citi buy rating despite mixed pipeline updates

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has retained a buy rating from Citi following a mixed set of pipeline updates, with the…

AstraZeneca: Pharmakonzern stoppt wichtige Studie zu Lungenkrebs-Mittel

Pharmariese AstraZeneca musste eine Studie für ein wichtiges Lungenkrebsmedikament stoppen. Es ist nicht der erste Fehlschlag in der jüngsten Zeit.…

AstraZeneca halts lung cancer trial in fresh pipeline setback

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has suffered its second pipeline setback in little over a month after halting a late-stage lung cancer…

AstraZeneca lung cancer drug combination extends survival in trial

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has reported positive results from a late-stage trial of a two-drug combination for a hard-to-treat form of…

FTSE 100 Live: Blue chips lose early lustre as mining rally runs out of steam

FTSE 100 up 4 at 10,755 Miners recover ground AZ resilient Posh house prices hit 10.55am: Drugmaker misses AstraZeneca shares proved…

LGND: XOMA Acquisition Closed

By John Vandermosten, CFANASDAQ: LGNDREAD THE FULL LGND RESEARCH NOTELigand Pharmaceuticals, Inc. (NASDAQ: LGND) reported second quarter 2026 results boasting…

ANALYSE-FLASH: Jefferies belässt Astrazeneca auf 'Buy' - Ziel 17500 Pence

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca auf "Buy"…

AstraZeneca-BMY megadeal talk sparks huge market rift

Two of the worlds biggest drugmakers moved in opposite directions on Monday, and the split says a lot about how…

Brokers split on AstraZeneca merger talk as shares recover some ground

Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) share price after…

AstraZeneca Investors See Little Logic in Bristol Tie-Up

AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don’t like the idea of a $400…

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger

Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?…

Analysts baffled by AstraZenecas interest in Bristol Myers Squibb

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts struggled…

Analysts baffled by AstraZenecas interest in Bristol Myers Squibb

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts struggled…

Stocks making the biggest moves premarket: Alibaba, AstraZeneca, eBay & more

These are the stocks posting the largest moves premarket.…

AstraZeneca slides after reports of Bristol Myers merger talks leave analysts perplexed

The companies have discussed a potential merger over several months, reports say.…

FTSE 100 held back by AstraZeneca as oil drops

The FTSE 100 started the week higher after Donald Trump said he planned to restart talks with Iran. The index rose in…

AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb

Shares in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) fell 7% to 11,723p on Monday after news that Britains biggest drugmaker is in talks…